CYSTIC FIBROSIS RESEARCH INSTITUTE (EIN 510169988) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1975

Legal Domicile

Principal Officer

BILL HULT

Phone

6506657576

Tax Period

2024-01-01 to 2024-12-31

CYSTIC FIBROSIS RESEARCH INSTITUTE, founded in 1975, is a community nonprofit in the Medical Research sector that reported $2.1M in total revenue in fiscal year 2024. The organization ran a surplus of $462K, a strong 22% operating margin.

Mission

TO FUND CYSTIC FIBROSIS RESEARCH, PROVIDE EDUCATION AND PERSONAL SUPPORT, AND TO SPREAD AWARENESS OF CYSTIC FIBROSIS, A LIFE THREATENING GENETIC DISEASE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,916,352

Program Service Revenue $13,707

Investment Income $124,582

Other Revenue $1,306

TOTAL REVENUE $2,055,947

Expense Breakdown

Grants Paid $528,720

Salaries & Benefits $471,713

Fundraising Expenses $134,087

Program Expenses $1,345,841

Other Expenses $593,795

TOTAL EXPENSES $1,594,228

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,055,947	$2,150,402	0.0%
Expenses	$1,594,228	$1,617,754	0.0%
Net Income	$461,719	$532,648	-0.1%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

150

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$116,238

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
FRANCINE BION	BOARD MEMBER	1.50	Director	$0	$0	$0
ZOE DAVIES	BOARD SECRETARY	1.50	Officer Director	$0	$0	$0
JULIE DESCH	BOARD MEMBER	1.50	Director	$0	$0	$0
ROHINI THUKRAL MCKEE	BOARD MEMBER	1.50	Director	$0	$0	$0
OSCAR A FLAMENCO	BOARD TREASURER	1.50	Officer Director	$0	$0	$0
ELYSE ELCONIN GOLDBERG	BOARD MEMBER	1.50	Director	$0	$0	$0
JEAN HANLEY	BOARD MEMBER	1.50	Director	$0	$0	$0
BILL HULT	PRESIDENT	1.50	Officer Director	$0	$0	$0
JESSICA MARTENS	VICE PRESIDENT	1.50	Officer Director	$0	$0	$0
DOUG MODLIN	BOARD MEMBER	1.50	Director	$0	$0	$0
RICHARD B MOSS	BOARD MEMBER	1.50	Director	$0	$0	$0
AREK PUZIA	BOARD MEMBER	1.50	Director	$0	$0	$0
AHMET ULUER	BOARD MEMBER	1.50	Director	$0	$0	$0
SIRI VAETH	EXECUTIVE DIRECTOR	40.00	Officer	$116,238	$0	$116,238

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,055,947	$1,594,228	$4,205,242	$461,719
2023	$2,150,402	$1,617,754	$3,727,841	$532,648
2022	$1,350,296	$1,525,935	$3,199,342	$-175,639
2021	$1,700,235	$1,149,954	$3,446,356	$550,281
2020	$1,304,810	$1,070,700	$2,964,531	$234,110
2019	$1,463,124	$1,345,742	$2,678,794	$117,382
2018	$1,750,385	$1,422,838	$2,572,885	$327,547

CYSTIC FIBROSIS RESEARCH INSTITUTE